pAktS473 supports CLL cell survival, but it is not sufficient to allow for CLL cell proliferation and thus provides a survival adaptation, but not a complete resistance to BTK inhibition. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.